Lutathera (lutetium-177 dotatate) has been approved by the FDA for treating of a type of rare cancer called Gastro-EnteroPancreatic NeuroEndocrine Tumors (GEP-NETs). GEP-NETs can be
A large study on pregnant women in South Korea found that taking antithyroid drugs during the first trimester of pregnancy was associated with a greater
One of the first-line treatments for patients with heart disease are cholesterol-lowering medications known as statins, which have been shown for years to reduce mortality
A new study published in The New England Journal of Medicine today showed that patients with advanced melanoma may experience significantly longer overall survival when
Central sleep apnea is a disorder where your breathing repeatedly pauses during sleep because the brain doesn’t send the proper signals to the diaphragm (these
An on-going clinical trial suggests that gene therapy is effective in stopping the progression of Cerebral Adrenoleukodystrophy Cerebral Adrenoleukodystrophy (CALD) is a severe and potentially
Verzenio (also known as abemaciclib) is a drug developed by Eli Lilly to treat HR-positive, HER2-negative patients with advanced or metastatic breast cancer who are
Researchers at The St. Michael’s Hospital and University of Toronto conducted a meta-analysis of 142 previous clinical trials to compare the safety and effectiveness of
Warfarin (also known as Coumadin) is a blood thinner frequently prescribed to individuals vulnerable to stroke, and to patients having joint replacement surgery. However, determining
